APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Pathology Image Analysis System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Pathology Image Analysis System Market Outlook and Growth Opportunities 2026

12 August 2026208 pages

Choose your research edition.

Industry ResearchAI Pathology Image Analysis System Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Pathology Image Analysis System Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal AI Pathology Image Analysis System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Pathology Image Analysis System Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Pathology Image Analysis System Market Analysis and Forecast 2026-2032182 pages · $4,950 USD

Market perspective

The global AI Pathology Image Analysis System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Pathology Image Analysis System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Pathology Image Analysis System market include Roche, Proscia, Indica Labs, Visiopharm, Aiforia, Lunit, Deep Bio, Mindpeak and Techcyte, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Pathology Image Analysis System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Pathology Image Analysis System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Pathology Image Analysis System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Pathology Image Analysis System market.

AI Pathology Image Analysis System Segment by Company

Roche

Proscia

Indica Labs

Visiopharm

Aiforia

Lunit

Deep Bio

Mindpeak

Techcyte

Qritive

Deciphex

Owkin

Aiosyn

DoMore Diagnostics

Stratipath

AIRA Matrix

Tribun Health

PathAI

Paige

Ibex Medical Analytics

AI Pathology Image Analysis System Segment by Type

Task-Specific AI Algorithms

Modular Image Analysis Suites

End-to-End AI Pathology Platforms

AI Model Development Platforms

AI-Enabled Image Management Systems

AI Pathology Image Analysis System Segment by Application

Cancer Diagnosis and Grading

Biomarker Scoring and Companion Diagnostics

Prognosis and Treatment Selection

Drug Discovery and Clinical Trials

Preclinical Safety Assessment

Pathology Workflow and Quality Control

AI Pathology Image Analysis System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Pathology Image Analysis System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Pathology Image Analysis System key companies, revenue, market share, and recent developments.

3. To split the AI Pathology Image Analysis System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Pathology Image Analysis System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Pathology Image Analysis System significant trends, drivers, influence factors in global and regions.

6. To analyze AI Pathology Image Analysis System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Image Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Image Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Image Analysis System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Pathology Image Analysis System industry.

Chapter 3: Detailed analysis of AI Pathology Image Analysis System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Pathology Image Analysis System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Pathology Image Analysis System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Pathology Image Analysis System Industry Trends Table 2. AI Pathology Image Analysis System Industry Drivers Table 3. AI Pathology Image Analysis System Industry Opportunities and Challenges Table 4. AI Pathology Image Analysis System Industry Restraints Table 5. Global AI Pathology Image Analysis System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Pathology Image Analysis System Revenue Share by Company (2021-2026) Table 7. Global AI Pathology Image Analysis System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Pathology Image Analysis System Key Company Manufacturing Base & Headquarters Table 9. Global AI Pathology Image Analysis System Company, Product Type & Application Table 10. Global AI Pathology Image Analysis System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Pathology Image Analysis System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Task-Specific AI Algorithms Table 15. Significant Companies of Modular Image Analysis Suites Table 16. Significant Companies of End-to-End AI Pathology Platforms Table 17. Significant Companies of AI Model Development Platforms Table 18. Significant Companies of AI-Enabled Image Management Systems Table 19. Global AI Pathology Image Analysis System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global AI Pathology Image Analysis System Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global AI Pathology Image Analysis System Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global AI Pathology Image Analysis System Sales Value Share by Type (2021-2026) Table 23. Global AI Pathology Image Analysis System Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Cancer Diagnosis and Grading Table 25. Significant Companies of Biomarker Scoring and Companion Diagnostics Table 26. Significant Companies of Prognosis and Treatment Selection Table 27. Significant Companies of Drug Discovery and Clinical Trials Table 28. Significant Companies of Preclinical Safety Assessment Table 29. Significant Companies of Pathology Workflow and Quality Control Table 30. Global AI Pathology Image Analysis System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Pathology Image Analysis System Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global AI Pathology Image Analysis System Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global AI Pathology Image Analysis System Sales Value Share by Application (2021-2026) Table 34. Global AI Pathology Image Analysis System Sales Value Share by Application (2027-2032) Table 35. Global AI Pathology Image Analysis System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Pathology Image Analysis System Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global AI Pathology Image Analysis System Sales Value Share by Region (2021-2026) Table 38. Global AI Pathology Image Analysis System Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global AI Pathology Image Analysis System Sales Value Share by Region (2027-2032) Table 40. Global AI Pathology Image Analysis System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global AI Pathology Image Analysis System Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global AI Pathology Image Analysis System Sales Value Market Share by Country (2021-2026) Table 43. Global AI Pathology Image Analysis System Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global AI Pathology Image Analysis System Sales Value Market Share by Country (2027-2032) Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Roche AI Pathology Image Analysis System Product Portfolio Table 49. Roche Recent Development Table 50. Proscia Company Information Table 51. Proscia Business Overview Table 52. Proscia AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Proscia AI Pathology Image Analysis System Product Portfolio Table 54. Proscia Recent Development Table 55. Indica Labs Company Information Table 56. Indica Labs Business Overview Table 57. Indica Labs AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Indica Labs AI Pathology Image Analysis System Product Portfolio Table 59. Indica Labs Recent Development Table 60. Visiopharm Company Information Table 61. Visiopharm Business Overview Table 62. Visiopharm AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Visiopharm AI Pathology Image Analysis System Product Portfolio Table 64. Visiopharm Recent Development Table 65. Aiforia Company Information Table 66. Aiforia Business Overview Table 67. Aiforia AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Aiforia AI Pathology Image Analysis System Product Portfolio Table 69. Aiforia Recent Development Table 70. Lunit Company Information Table 71. Lunit Business Overview Table 72. Lunit AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Lunit AI Pathology Image Analysis System Product Portfolio Table 74. Lunit Recent Development Table 75. Deep Bio Company Information Table 76. Deep Bio Business Overview Table 77. Deep Bio AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Deep Bio AI Pathology Image Analysis System Product Portfolio Table 79. Deep Bio Recent Development Table 80. Mindpeak Company Information Table 81. Mindpeak Business Overview Table 82. Mindpeak AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Mindpeak AI Pathology Image Analysis System Product Portfolio Table 84. Mindpeak Recent Development Table 85. Techcyte Company Information Table 86. Techcyte Business Overview Table 87. Techcyte AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Techcyte AI Pathology Image Analysis System Product Portfolio Table 89. Techcyte Recent Development Table 90. Qritive Company Information Table 91. Qritive Business Overview Table 92. Qritive AI Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Qritive AI Pathology Image Analysis System Product Portfolio Table 94. Qritive Recent Development Table 95. Deciphex Company Information Table 96. Deciphex Business Overview Table 97. Deciphex AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Deciphex AI Pathology Image Analysis System Product Portfolio Table 99. Deciphex Recent Development Table 100. Owkin Company Information Table 101. Owkin Business Overview Table 102. Owkin AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Owkin AI Pathology Image Analysis System Product Portfolio Table 104. Owkin Recent Development Table 105. Aiosyn Company Information Table 106. Aiosyn Business Overview Table 107. Aiosyn AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Aiosyn AI Pathology Image Analysis System Product Portfolio Table 109. Aiosyn Recent Development Table 110. DoMore Diagnostics Company Information Table 111. DoMore Diagnostics Business Overview Table 112. DoMore Diagnostics AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. DoMore Diagnostics AI Pathology Image Analysis System Product Portfolio Table 114. DoMore Diagnostics Recent Development Table 115. Stratipath Company Information Table 116. Stratipath Business Overview Table 117. Stratipath AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Stratipath AI Pathology Image Analysis System Product Portfolio Table 119. Stratipath Recent Development Table 120. AIRA Matrix Company Information Table 121. AIRA Matrix Business Overview Table 122. AIRA Matrix AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. AIRA Matrix AI Pathology Image Analysis System Product Portfolio Table 124. AIRA Matrix Recent Development Table 125. Tribun Health Company Information Table 126. Tribun Health Business Overview Table 127. Tribun Health AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Tribun Health AI Pathology Image Analysis System Product Portfolio Table 129. Tribun Health Recent Development Table 130. PathAI Company Information Table 131. PathAI Business Overview Table 132. PathAI AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. PathAI AI Pathology Image Analysis System Product Portfolio Table 134. PathAI Recent Development Table 135. Paige Company Information Table 136. Paige Business Overview Table 137. Paige AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Paige AI Pathology Image Analysis System Product Portfolio Table 139. Paige Recent Development Table 140. Ibex Medical Analytics Company Information Table 141. Ibex Medical Analytics Business Overview Table 142. Ibex Medical Analytics AI Pathology Image Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Ibex Medical Analytics AI Pathology Image Analysis System Product Portfolio Table 144. Ibex Medical Analytics Recent Development Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. AI Pathology Image Analysis System Product Image Figure 2. Global AI Pathology Image Analysis System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Pathology Image Analysis System Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Pathology Image Analysis System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Task-Specific AI Algorithms Image Figure 8. Modular Image Analysis Suites Image Figure 9. End-to-End AI Pathology Platforms Image Figure 10. AI Model Development Platforms Image Figure 11. AI-Enabled Image Management Systems Image Figure 12. Global AI Pathology Image Analysis System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global AI Pathology Image Analysis System Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global AI Pathology Image Analysis System Sales Value Share by Type (2021-2032) Figure 15. Cancer Diagnosis and Grading Image Figure 16. Biomarker Scoring and Companion Diagnostics Image Figure 17. Prognosis and Treatment Selection Image Figure 18. Drug Discovery and Clinical Trials Image Figure 19. Preclinical Safety Assessment Image Figure 20. Pathology Workflow and Quality Control Image Figure 21. Global AI Pathology Image Analysis System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Pathology Image Analysis System Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global AI Pathology Image Analysis System Sales Value Share by Application (2021-2032) Figure 24. Global AI Pathology Image Analysis System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global AI Pathology Image Analysis System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America AI Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 27. North America AI Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe AI Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 29. Europe AI Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific AI Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific AI Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America AI Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 33. South America AI Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa AI Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa AI Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Task-Specific AI Algorithms
  • Modular Image Analysis Suites
  • End-to-End AI Pathology Platforms
  • AI Model Development Platforms
  • AI-Enabled Image Management Systems
Applications
  • Cancer Diagnosis and Grading
  • Biomarker Scoring and Companion Diagnostics
  • Prognosis and Treatment Selection
  • Drug Discovery and Clinical Trials
  • Preclinical Safety Assessment
  • Pathology Workflow and Quality Control
Companies covered
  • Roche
  • Proscia
  • Indica Labs
  • Visiopharm
  • Aiforia
  • Lunit
  • Deep Bio
  • Mindpeak
  • Techcyte
  • Qritive
  • Deciphex
  • Owkin
  • Aiosyn
  • DoMore Diagnostics
  • Stratipath
  • AIRA Matrix
  • Tribun Health
  • PathAI
  • Paige
  • Ibex Medical Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Pathology Image Analysis System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Pathology Image Analysis System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Pathology Image Analysis System Market Dynamics
  1. 2.1 AI Pathology Image Analysis System Industry Trends
  2. 2.2 AI Pathology Image Analysis System Industry Drivers
  3. 2.3 AI Pathology Image Analysis System Industry Opportunities and Challenges
  4. 2.4 AI Pathology Image Analysis System Industry Restraints
3 AI Pathology Image Analysis System Market by Company
  1. 3.1 Global AI Pathology Image Analysis System Company Revenue Ranking in 2025
  2. 3.2 Global AI Pathology Image Analysis System Revenue by Company (2021-2026)
  3. 3.3 Global AI Pathology Image Analysis System Company Ranking (2024-2026)
  4. 3.4 Global AI Pathology Image Analysis System Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Pathology Image Analysis System Company Product Type and Application
  6. 3.6 Global AI Pathology Image Analysis System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Pathology Image Analysis System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Pathology Image Analysis System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Pathology Image Analysis System Market by Type
  1. 4.1 AI Pathology Image Analysis System Type Introduction
  2. 4.1.1 Task-Specific AI Algorithms
  3. 4.1.2 Modular Image Analysis Suites
  4. 4.1.3 End-to-End AI Pathology Platforms
  5. 4.1.4 AI Model Development Platforms
  6. 4.1.5 AI-Enabled Image Management Systems
  7. 4.2 Global AI Pathology Image Analysis System Sales Value by Type
  8. 4.2.1 Global AI Pathology Image Analysis System Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global AI Pathology Image Analysis System Sales Value by Type (2021-2032)
  10. 4.2.3 Global AI Pathology Image Analysis System Sales Value Share by Type (2021-2032)
5 AI Pathology Image Analysis System Market by Application
  1. 5.1 AI Pathology Image Analysis System Application Introduction
  2. 5.1.1 Cancer Diagnosis and Grading
  3. 5.1.2 Biomarker Scoring and Companion Diagnostics
  4. 5.1.3 Prognosis and Treatment Selection
  5. 5.1.4 Drug Discovery and Clinical Trials
  6. 5.1.5 Preclinical Safety Assessment
  7. 5.1.6 Pathology Workflow and Quality Control
  8. 5.2 Global AI Pathology Image Analysis System Sales Value by Application
  9. 5.2.1 Global AI Pathology Image Analysis System Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global AI Pathology Image Analysis System Sales Value by Application (2021-2032)
  11. 5.2.3 Global AI Pathology Image Analysis System Sales Value Share by Application (2021-2032)
6 AI Pathology Image Analysis System Regional Value Analysis
  1. 6.1 Global AI Pathology Image Analysis System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Pathology Image Analysis System Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Pathology Image Analysis System Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Pathology Image Analysis System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Pathology Image Analysis System Sales Value (2021-2032)
  7. 6.3.2 North America AI Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Pathology Image Analysis System Sales Value (2021-2032)
  10. 6.4.2 Europe AI Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Pathology Image Analysis System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Pathology Image Analysis System Sales Value (2021-2032)
  16. 6.6.2 South America AI Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Pathology Image Analysis System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
7 AI Pathology Image Analysis System Country-level Value Analysis
  1. 7.1 Global AI Pathology Image Analysis System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Pathology Image Analysis System Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Pathology Image Analysis System Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Pathology Image Analysis System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche AI Pathology Image Analysis System Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Proscia
  8. 8.2.1 Proscia Company Information
  9. 8.2.2 Proscia Business Overview
  10. 8.2.3 Proscia AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Proscia AI Pathology Image Analysis System Product Portfolio
  12. 8.2.5 Proscia Recent Developments
  13. 8.3 Indica Labs
  14. 8.3.1 Indica Labs Company Information
  15. 8.3.2 Indica Labs Business Overview
  16. 8.3.3 Indica Labs AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Indica Labs AI Pathology Image Analysis System Product Portfolio
  18. 8.3.5 Indica Labs Recent Developments
  19. 8.4 Visiopharm
  20. 8.4.1 Visiopharm Company Information
  21. 8.4.2 Visiopharm Business Overview
  22. 8.4.3 Visiopharm AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Visiopharm AI Pathology Image Analysis System Product Portfolio
  24. 8.4.5 Visiopharm Recent Developments
  25. 8.5 Aiforia
  26. 8.5.1 Aiforia Company Information
  27. 8.5.2 Aiforia Business Overview
  28. 8.5.3 Aiforia AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aiforia AI Pathology Image Analysis System Product Portfolio
  30. 8.5.5 Aiforia Recent Developments
  31. 8.6 Lunit
  32. 8.6.1 Lunit Company Information
  33. 8.6.2 Lunit Business Overview
  34. 8.6.3 Lunit AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lunit AI Pathology Image Analysis System Product Portfolio
  36. 8.6.5 Lunit Recent Developments
  37. 8.7 Deep Bio
  38. 8.7.1 Deep Bio Company Information
  39. 8.7.2 Deep Bio Business Overview
  40. 8.7.3 Deep Bio AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Deep Bio AI Pathology Image Analysis System Product Portfolio
  42. 8.7.5 Deep Bio Recent Developments
  43. 8.8 Mindpeak
  44. 8.8.1 Mindpeak Company Information
  45. 8.8.2 Mindpeak Business Overview
  46. 8.8.3 Mindpeak AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mindpeak AI Pathology Image Analysis System Product Portfolio
  48. 8.8.5 Mindpeak Recent Developments
  49. 8.9 Techcyte
  50. 8.9.1 Techcyte Company Information
  51. 8.9.2 Techcyte Business Overview
  52. 8.9.3 Techcyte AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Techcyte AI Pathology Image Analysis System Product Portfolio
  54. 8.9.5 Techcyte Recent Developments
  55. 8.10 Qritive
  56. 8.10.1 Qritive Company Information
  57. 8.10.2 Qritive Business Overview
  58. 8.10.3 Qritive AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qritive AI Pathology Image Analysis System Product Portfolio
  60. 8.10.5 Qritive Recent Developments
  61. 8.11 Deciphex
  62. 8.11.1 Deciphex Company Information
  63. 8.11.2 Deciphex Business Overview
  64. 8.11.3 Deciphex AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Deciphex AI Pathology Image Analysis System Product Portfolio
  66. 8.11.5 Deciphex Recent Developments
  67. 8.12 Owkin
  68. 8.12.1 Owkin Company Information
  69. 8.12.2 Owkin Business Overview
  70. 8.12.3 Owkin AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Owkin AI Pathology Image Analysis System Product Portfolio
  72. 8.12.5 Owkin Recent Developments
  73. 8.13 Aiosyn
  74. 8.13.1 Aiosyn Company Information
  75. 8.13.2 Aiosyn Business Overview
  76. 8.13.3 Aiosyn AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aiosyn AI Pathology Image Analysis System Product Portfolio
  78. 8.13.5 Aiosyn Recent Developments
  79. 8.14 DoMore Diagnostics
  80. 8.14.1 DoMore Diagnostics Company Information
  81. 8.14.2 DoMore Diagnostics Business Overview
  82. 8.14.3 DoMore Diagnostics AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 DoMore Diagnostics AI Pathology Image Analysis System Product Portfolio
  84. 8.14.5 DoMore Diagnostics Recent Developments
  85. 8.15 Stratipath
  86. 8.15.1 Stratipath Company Information
  87. 8.15.2 Stratipath Business Overview
  88. 8.15.3 Stratipath AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Stratipath AI Pathology Image Analysis System Product Portfolio
  90. 8.15.5 Stratipath Recent Developments
  91. 8.16 AIRA Matrix
  92. 8.16.1 AIRA Matrix Company Information
  93. 8.16.2 AIRA Matrix Business Overview
  94. 8.16.3 AIRA Matrix AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AIRA Matrix AI Pathology Image Analysis System Product Portfolio
  96. 8.16.5 AIRA Matrix Recent Developments
  97. 8.17 Tribun Health
  98. 8.17.1 Tribun Health Company Information
  99. 8.17.2 Tribun Health Business Overview
  100. 8.17.3 Tribun Health AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tribun Health AI Pathology Image Analysis System Product Portfolio
  102. 8.17.5 Tribun Health Recent Developments
  103. 8.18 PathAI
  104. 8.18.1 PathAI Company Information
  105. 8.18.2 PathAI Business Overview
  106. 8.18.3 PathAI AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  107. 8.18.4 PathAI AI Pathology Image Analysis System Product Portfolio
  108. 8.18.5 PathAI Recent Developments
  109. 8.19 Paige
  110. 8.19.1 Paige Company Information
  111. 8.19.2 Paige Business Overview
  112. 8.19.3 Paige AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Paige AI Pathology Image Analysis System Product Portfolio
  114. 8.19.5 Paige Recent Developments
  115. 8.20 Ibex Medical Analytics
  116. 8.20.1 Ibex Medical Analytics Company Information
  117. 8.20.2 Ibex Medical Analytics Business Overview
  118. 8.20.3 Ibex Medical Analytics AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ibex Medical Analytics AI Pathology Image Analysis System Product Portfolio
  120. 8.20.5 Ibex Medical Analytics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst